Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

In vivo assessment of brain white matter inflammation in multiple sclerosis with 18F-PBR111 PET

Colasanti, Alessandro, Guo, Qi, Muhlert, Nils, Giannetti, Paolo, Onega, Mayca, Newbould, Rexford D., Ciccarelli, Olga, Rison, Stuart, Thomas, Charlotte, Nicholas, Richard, Muraro, Paolo A., Malik, Omar, Owen, David R., Piccini, Paola, Gunn, Roger N., Rabiner, Eugenii A. and Matthews, Paul M. 2014. In vivo assessment of brain white matter inflammation in multiple sclerosis with 18F-PBR111 PET. Journal of Nuclear Medicine 55 (7) , pp. 1112-1118. 10.2967/jnumed.113.135129

Full text not available from this repository.

Abstract

PET radioligand binding to the 18-kD translocator protein (TSPO) in the brains of patients with multiple sclerosis (MS) primarily reflects activated microglia and macrophages. We previously developed genetic stratification for accurate quantitative estimation of TSPO using second-generation PET radioligands. In this study, we used 18F-PBR111 PET and MR imaging to measure relative binding in the lesional, perilesional, and surrounding normal-appearing white matter of MS patients, as an index of the innate immune response. Methods: 18F-PBR111 binding was quantified in 11 MS patients and 11 age-matched healthy volunteers, stratified according to the rs6971 TSPO gene polymorphism. Fluid-attenuated inversion recovery and magnetization transfer ratio (MTR) MR imaging were used to segment the white matter in MS patients as lesions, perilesional volumes, nonlesional white matter with reduced MTR, and nonlesional white matter with normal MTR. Results: 18F-PBR111 binding was higher in the white matter lesions and perilesional volumes of MS patients than in white matter of healthy controls (P < 0.05). Although there was substantial heterogeneity in binding between different lesions, a within-subject analysis showed higher 18F-PBR111 binding in MS lesions (P < 0.05) and in perilesional (P < 0.05) and nonlesional white matter with reduced MTR (P < 0.005) than in nonlesional white matter with a normal MTR. A positive correlation was observed between the mean 18F-PBR111 volume of distribution increase in lesions relative to nonlesional white matter with a normal MTR and the MS severity score (Spearman ρ = 0.62, P < 0.05). Conclusion: This study demonstrates that quantitative TSPO PET with a second-generation radioligand can be used to characterize innate immune responses in MS in vivo and provides further evidence supporting an association between the white matter TSPO PET signal in lesions and disease severity. Our approach is practical for extension to studies of the role of the innate immune response in MS for differentiation of antiinflammatory effects of new medicines and their longer term impact on clinical outcome.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Cardiff University Brain Research Imaging Centre (CUBRIC)
Psychology
Subjects: B Philosophy. Psychology. Religion > BF Psychology
Uncontrolled Keywords: Multiple sclerosis; TSPO; microglia; lesion; PET; MTR.
Publisher: Society of Nuclear Medicine
ISSN: 0161-5505
Last Modified: 04 Jun 2017 06:35
URI: http://orca-mwe.cf.ac.uk/id/eprint/62522

Citation Data

Cited 4 times in Google Scholar. View in Google Scholar

Cited 46 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item